Sunday, July 22, 2018
Taiwan Unveils Latest Medical Inventions to Advance Science During FIME in Orlando
ORLANDO, Fla., July 20, 2018 /PRNewswire/ -- Health Execs, physicians and diplomats were awed by the new medical devices presented by three Taiwanese companies that will enhance surgeon skills, accurately detect thyroid cancer and relieve patient bed sores. "Taiwan Medical Marvels" was the theme of this international p.....
RevitaLash® Cosmetics Welcomes New Addition to Color Cosmetic Line
VENTURA, Calif., July 20, 2018 /PRNewswire/ -- RevitaLash® Cosmetics, the leading Physician led brow and lash brand, is pleased to announce the latest addition to its illustrious selection of products, the Double-Ended Volume Set. The brand's award winning Volumizing Primer and Volumizing Mascara have merged in.....

IBA SA : Strategic review of IBA Dosimetry business

Global Companion Diagnostics Market Research Analysis by Type, Product, Material, End User, Geography 2018 - 2025
Companion diagnostics are quickly rising as key parts in customized medication. Late FDA endorsements of medications, for example, Zelboraf and Xalkori have supported b...
WuXi STA and Antengene Sign Development and Manufacturing Agreement
SHANGHAI, July 19, 2018 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - and Antengene Corporation, a biopharmaceutical company, recently announced a strategic partnership for the CMC development and manufacturing of innovative oncology drugs. Under the terms of the collaboration, WuXi .....
Study Published in The Lancet Shows Benefit of Baricitinib 4 mg for the Treatment of Systemic Lupus Erythematosus (SLE)
INDIANAPOLIS, July 19, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that results of a global systemic lupus erythematosus (SLE) Phase 2 study for baricitinib were published by The Lancet. The study, the first completed Phase 2 study of a JAK inhibitor in S.....
Journal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos® (daunorubicin and cytarabine) Liposome for Injection
DUBLIN, July 19, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that data from the pivotal Phase 3 study of Vyxeos® (daunorubicin and cytarabine) liposome for injection compared to standard of care cytarabine and daunorubicin (7+3) were published online in the
Ultrasound Devices Market Latest Study by Applications-Diagnostic, Therapeutic etc. with Competitive Landscape during 2018-2023
The Nutritional Bar Market is growing at a CAGR of 6.9% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, th...
Amgen And Cedars-Sinai Partner For Improved Healthcare Quality
THOUSAND OAKS, Calif. and LOS ANGELES, July 19, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Cedars-Sinai Medical Center today announced a partnership to help support the improvement of healthcare quality in the treatment of multiple therapeutic areas that could include oncology, cardiovascula.....


  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally -

    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines